Survey and analysis of insurance for volunteers in clinical trials of new drugs and medical instruments

SHAN Ai-lian,LIANG Yan,CUI Yi-min
DOI: https://doi.org/10.3969/j.issn.1001-6821.2013.07.001
2013-01-01
Abstract:Objective To investigate the current situation of insurance support for volunteers in clinical trials of new drugs and medical instruments.Methods The data of insurance support for volunteers in clinical trials of new drugs and medical instruments in Peking University first hospital in recent two years were analyzed.Results The sponsors did not provide the insurance for volunteers according to the regulations of the state in most of clinical trails,except some global multi-center trials that damaged the rights of volunteers seriously.Moreover,types of insurance were incomplete that caused inadequate identification of serious adverse effect and inadequate compensation to related volunteers.Conclusion At present,more and more subjects and sponsor,investigator disputes increase after the adverse drug events because the sponsor did not provide insurance in the clinical trial for subjects so we should pay attention to it.
What problem does this paper attempt to address?